/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/
WINNIPEG, Jan. 17, 2018 /CNW/ - Delta 9 Cannabis Inc. (TSXV:NINE) ("Delta 9" or the "Company") is pleased to announce that the TSX Venture Exchange (the "Exchange") has approved the listing for trading of its common share purchase warrants (the "Warrants") issued on December 28, 2017 pursuant to its short form prospectus offering. There are currently 8,521,500 Warrants issued and outstanding. Each Warrant entitles the holder thereof to purchase one common share of the Company at a price of $3.25 per share until June 28, 2020. The Exchange has informed the Company that the Warrants will begin trading at the opening of the Exchange on Wednesday, January 17, 2018 under the symbol "NINE.WT".
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an approximately 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9's shares trade on the TSX Venture Exchange under the symbol "NINE".
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Delta 9 Cannabis Inc.
For further information: Gary Symons, Director of Communication, Delta 9 Cannabis Inc., [email protected], 250.300.9352